Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases.
暂无分享,去创建一个
A. Rosenwald | B. Sander | E. Campo | K. Stamatopoulos | N. Darzentas | R. Rosenquist | C. Pott | F. Davi | A. Tsaftaris | M. Dreyling | C. Geisler | M. Ponzoni | K. Beldjord | A. Anagnostopoulos | P. Groenen | M. Delfau-Larue | P. Ghia | A. Hadzidimitriou | A. Agathangelidis | T. Papadaki | F. Murray | A. Dagklis | L. Pedersen | A. Kolstad | P. Mavragani-Tsipidou | P. Rombout | A. López | Antonis Dagklis
[1] N. Chiorazzi,et al. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. , 2011, Blood.
[2] A. Wiestner,et al. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. , 2011, Blood.
[3] R. Advani,et al. The Btk Inhibitor, PCI-32765, Induces Durable Responses with Minimal Toxicity In Patients with Relapsed/Refractory B-Cell Malignancies: Results From a Phase I Study , 2010 .
[4] K. Stamatopoulos,et al. The Composition of the B Cell Receptor Repertoire In 7428 Cases of Chronic Lymphocytic Leukemia: One Third Stereotyped, Two Thirds Heterogeneous - What Does This Mean? , 2010 .
[5] F. Berger,et al. Over 30% of Patients with Splenic Marginal Zone Lymphoma Express Distinctive Antigen Receptors Utilizing a Single Immunoglogulin Variable Gene: Implications for the Origin and Selection of the Neoplastic Cells , 2010 .
[6] J. Tuscano,et al. The Bispecific Anti-CD20/CD22 Antibody (Bs20x22) Has More Lymphomacidal Activity Than the Parent Antibodies Both Alone or In Combination , 2010 .
[7] F. Rieux-Laucat,et al. Onset of Autoimmunity In ALPS as a Consequence of Genetic Defects Accumulation , 2010 .
[8] N. Schmitz,et al. CNS Disease In Younger Patients ( , 2010 .
[9] A. Berk,et al. Dominant Negative Form of PAX5 Is Generated by Multimerization of Its DNA Binding Domain , 2010 .
[10] David Kipling,et al. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. , 2010, Blood.
[11] L. Staudt,et al. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. , 2010, Blood.
[12] R. Siebert,et al. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma , 2010, Genes, chromosomes & cancer.
[13] P. Lipsky,et al. Identification and Characterization of a Human CD5+ Pre-Naive B Cell Population1 , 2009, The Journal of Immunology.
[14] Xiao-Jie Yan,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2007 .
[15] Marie-Paule Lefranc,et al. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis , 2008, Nucleic Acids Res..
[16] R. Rosenquist,et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. , 2008, Blood.
[17] A. Plebani,et al. CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies , 2008, The Journal of Immunology.
[18] E. Thelander,et al. Molecular genetic characterization reveals new subsets of mantle cell lymphoma , 2008, Leukemia & lymphoma.
[19] Nikolaos Laoutaris,et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. , 2007, Blood.
[20] E. Campo,et al. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.
[21] M. Neuberger,et al. Molecular mechanisms of antibody somatic hypermutation. , 2007, Annual review of biochemistry.
[22] J. D. Capra,et al. A novel human B cell subpopulation representing the initial germinal center population to express AID. , 2007, Blood.
[23] E. Schuuring,et al. Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity , 2006, Modern Pathology.
[24] Nikolaos Laoutaris,et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.
[25] Patrice Duroux,et al. IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences , 2005, Nucleic Acids Res..
[26] P. Lipsky,et al. Identification and characterization of circulating human transitional B cells. , 2005, Blood.
[27] Ralf Küppers,et al. Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.
[28] Jérôme Lane,et al. IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..
[29] Steven L. Allen,et al. Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.
[30] Mats Ohlin,et al. Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factor , 2004, Journal of molecular recognition : JMR.
[31] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[32] H. Müller-Hermelink,et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. , 2003, Blood.
[33] D. Catovsky,et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. , 2003, Blood.
[34] B. Sander,et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. , 2003, Blood.
[35] E. Campo,et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. , 2003, Blood.
[36] D. Isenberg,et al. Systematic analysis of sequences of anti-DNA antibodies—relevance to theories of origin and pathogenicity , 2002, Lupus.
[37] R. Rosenquist,et al. Somatic hypermutation and VH gene usage in mantle cell lymphoma , 2002, European journal of haematology.
[38] J. Spencer,et al. Somatic hypermutation and B-cell lymphoma. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[39] M. Brüggemann,et al. Rearrangement of the human heavy chain variable region gene V3–23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region , 2001, Clinical and experimental immunology.
[40] J. Xu,et al. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. , 2000, Immunity.
[41] D. Burton,et al. Human autoantibody recognition of DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] S Henikoff,et al. Performance evaluation of amino acid substitution matrices , 1993, Proteins.
[43] K. Stamatopoulos,et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence , 2010, Leukemia.
[44] W. Hiddemann,et al. Current treatment standards and emerging strategies in mantle cell lymphoma. , 2009, Hematology. American Society of Hematology. Education Program.
[45] O. O’Connor. Mantle cell lymphoma: identifying novel molecular targets in growth and survival pathways. , 2007, Hematology. American Society of Hematology. Education Program.
[46] Robert Sabatier,et al. IMGT standardized criteria for statistical analysis of immunoglobulin V‐REGION amino acid properties , 2004, Journal of molecular recognition : JMR.
[47] Marie-Paule Lefranc,et al. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs , 2004, ISMB/ECCB.
[48] V. Giudicelli,et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.
[49] T. Hamblin,et al. The occurrence and significance of V gene mutations in B cell-derived human malignancy. , 2001, Advances in cancer research.